Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
XNCRthis companyXencor, Inc.	$38.36	-12.35×	1.79×	9.05×	-27.04×	-122.2%	91.6%	-141.4%	-73.2%	-14.5%	-21.5%	-12.2%	0.3×	-2.85×	-5.56×	6.25×	0.0%	2	4.41	2	C
CLDXCelldex Therapeutics, Inc.	$31.21	-6.96×	3.43×	1,204.09×	-6.97×	-99.2%	100.0%	-19160.0%	-17253.3%	-49.1%	-53.9%	-11.8%	0×	0.1×	0×	10.49×	0.0%	2	16.42	2	C
MGNXMacroGenics, Inc.	$2.44	-1.36×	1.83×	0.68×	-2.54×	-2714.5%	71.1%	-48.7%	-49.9%	-134.2%	-33.0%	-81.6%	1.92×	-0.83×	-8.56×	5.1×	0.0%	1	-4.43	1	D+
NKTRNektar Therapeutics	$37.56	-4.35×	7.94×	12.91×	-6.18×	-172.6%	100.0%	-236.8%	-297.1%	-182.6%	-52.8%	-29.3%	1.66×	-0.98×	-4.99×	4.97×	0.0%	1	-1.18	2	C
NRIXNurix Therapeutics, Inc.	$15.81	-5.54×	2.72×	17.45×	-5.2×	-213.0%	77.5%	-340.2%	-314.9%	-49.1%	-47.3%	-18.0%	0.1×	0.78×	0×	7.02×	0.0%	7	9.1	4	A-
Peer median	—	-4.94×	3.07×	15.18×	-5.69×	-192.8%	88.8%	-288.5%	-306.0%	-91.7%	-50.0%	-23.6%	0.88×	-0.36×	-2.5×	6.06×	0.0%	2	3.96	2	—